Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q1 EPS of ($0.37), $0.04 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.